FDA Investigator Sarah Kennett, PhD

Sarah Kennett, PhD has conducted inspections on 3 sites in 3 countries as of 27 Mar 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
3
Last Inspection Date:
27 Mar 2017
Investigator Role:
FDA Investigation Participant
Redica ID:
100002971
Countries of Inspections:
India, Korea (Republic of), United States of America
FDA Investigators that have inspected at least one site in common with Sarah Kennett, PhD:
Alicia M Mozzachio, Arsen Karapetyan, Bijoy Panicker, Bo Chi, PhD, Candace Y Gomez Broughton, Charisse K Green, Deborah Schmiel, PhD, Diane L Raccasi, Dogbeda F Mackenzie, Dr. Barbara D Paul, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Willie Wilson, PhD, Eileen A Liu, Guerlain Ulysse, Hyung Yul Lee, J Paul Kirwan, PhD, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, Jay T Wong, Jeffrey P Raimondi, Jens Fricke, Joel D Martinez, Kalavati Suvarna, PhD, Kristen Nickens, PhD, Lakshmi Narasimhan, PhD, Laura Fontan, MS, Laurel A Beer, Laurie Nelson, LCDR Chad N Thompson, Linda F Murphy, Lindsey Brown, PhD, Lucila B Nwatu, Madushini Dharmasena, PhD, Margaret E Sarles, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Marion Michaelis, Matthew B Casale, Maxwell Van Tassell, PhD, Merry Christie, PhD, Michael Shanks, MS, Michelle Yclark Stuart, Milos Dokmanovic, PhD, Mindy M Chou, Monica Markovski, PhD, Muralidhara B Gavini, PhD, Ogechi C Nna, Omotunde O Osunsanmi, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Patrick J Lynch, Paul Mouris, Phillip Angart, PhD, Prabhu P Raju, Rajiv R Srivastava, Regina T Brown, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, Robert J Martin, S Lori Brown, PhD MPH, Sandra A Hughes, Sarah Arden, Sony Mathews, Steven Fong, MS, PhD, Thuy T Nguyen, LCDR, Tzanko Stantchev, Virginia Carroll, PhD, Wayne E Seifert, Yun Wu, PhD, Zhong Li, PhD

Sarah Kennett, PhD's Documents

Publish Date Document Type Title
May, 2011 FDA 483 Regeneron Pharmaceuticals, Inc. - Form 483, 2011-05-20
June, 2016 FDA 483 Samsung Biologics Co., Ltd. - Form 483, 2016-06-22
April, 2017 FDA 483 Biocon Biologics Limited - Form 483, 2017-04-07

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more